Downloaded from https://www.everyspec.com 10–26). If found fit for duty, the Soldier may be deployed unless he/she cannot function in the specific environment in which he/she is being assigned. Soldiers who meet medical retention standards but have a 3 in the profile cannot be deployed unless cleared by an MMRB. (8) Psychiatric. (a) A psychiatric condition controlled by medication should not automatically lead to nondeployment. Soldiers with a controlled psychiatric illness can still deploy. The recommendation of deployability should rest with the clinical judgement of the treating physician or other privileged provider, in consultation with the unit commander.
If there are any questions on the safety of psychiatric medication, a psychiatrist should be consulted. (b) Medications that may be used safely in theater include selective serotonin re-uptake inhibitors and sleep medications. In general, anti-manic and anti-psychotic medications should not be used in theater because of their side- effects. (9) History of heat injuries. See paragraph 3–45 for profile guidance and MEB/PEB criteria. If there is any evidence of significant heat intolerance, the Soldier should not deploy to warm austere climates. (10) Pregnancy. Pregnant Soldiers will not deploy. (11) History of cancer.
Soldiers with a history of cancer who have been returned to duty but have a requirement for periodic monitoring every 6 months or less should not deploy. (12) Chronic infectious diseases (HIV, Hepatitis B or C) . Soldiers will not deploy into the combat theater of operations. If found fit by a PEB, Soldiers may deploy to Europe or Korea (Host Nation permitting). (13) Abnormal Cervical Cytology. Soldiers with recently treated moderate or severe dysplasia may only be deployed to austere environments if coordination is arranged via the unit commander and theater surgeon to ensure follow-up evaluation 7 to 9 months after initial evaluation and treatment. (14) Malignant hyperthermia.
Soldiers with history of malignant hyperthermia should not be assigned to areas where complete anesthesia services are unavailable or to austere environments. (15) Contact lenses. Soldiers who must wear contact lenses to achieve vision standards; who cannot satisfactorily perform their MOS with their best spectacle correction or fall below vision retention standards with their best spectacle prescription should not deploy. Contact lens wear is not authorized in field environments or while deployed. (16) Miscellaneous conditions.
Soldiers pending and scheduled for required surgeries or still in rehabilitation post surgery with temporary profiles, pain syndromes requiring the use of medications (beyond simple NSAIDS), or the use of transcutaneous electrical nerve stimulator units, should not deploy. (17) Medications. Soldiers taking medications should not automatically be disqualified for any duty assignment. Medications used for serious and/or complex medical conditions are not usually suitable for extended deployments. The medications on the list below are most likely to be used for serious and/or complex medical conditions that could likely result in adverse health consequences.
This is not an all-inclusive listing of medications that may render an individual non-deployable but is provided as a guideline to be used during pre-deployment medical screening. Because some medications are used for multiple reasons, any medical screening should take into account whether the drug is being used for a serious and/or complex medical condition or another use that might be appropriate for a deploying Soldier. A complete medical evaluation should be initiated on those personnel regularly taking the following medications: • Antiarrhythmics. • Antiasthmatics (long acting beta-agonists and inhaled corticosteroids only). • Anti-cancer/chemotherapy agents.
• Anticoagulants (for example, heparin, warfarin). • Anticonvulsants (for the treatment of seizure disorder). • Antidepressants (moderate to severe cases, bipolar, or unstable patients). • Anti-gout medications (for example, allopurinol, colchicines). • Anti-HIV medications. • Antimania (lithium). • Antiparkinsonians. • Antipsychotics. • Antithyroid medications (propylthiouracil (PTU), methimozole). • Anti-tumor necrosis factor (for example, enteracept, and so on). • Any injectable medications. • Any type of insulin. • Any type of medication (oral or injected) used for the purpose of treating diabetes. • Chronic anxiolytics.
• Chronic immunosuppressants (for example, azathioprine, cyclosporin, and so on). • Chronic narcotic analgesics. • Coronary vasodilators (nitrates). • Heart failure medications. • Hematologics (for example, EPO, G-CSF, GM–CSF, and so on). • Immunomodulators (for example, interferons, methotrexate, and so on). 60 AR 40–501 • 14 December 2007